Transorbent hydrocellular wound dressing from Maersk Medical.
This article describes the healing process and explores the role of wound dressings in promoting the formation of granulation tissue. With so many products available it is important that nurses base their decisions on known clinical effectiveness and the best available evidence. Transorbent hydrocellular dressing from Maersk Medical is reviewed along with research into its efficacy. To determine the value of Transorbent in today's dynamic wound care arena, the literature will be examined and the product's ability to fulfil the criteria for the ideal wound dressing will be considered.
Trudgian
J
J
Tissue Viability, Royal Cornwall Hospitals, NHS Trust, UK.
D006801:Humans; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D009779:Occlusive Dressings; D011140:Polyurethanes; D012883:Skin Ulcer / Q000628:therapy*; D014945:Wound Healing; D014947:Wounds and Injuries / Q000628:therapy*
D011140:Polyurethanes; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate